SSD inhibited TNF-α-induced NF-κB activation and the expression of its target genes, which are involved in cancer cell proliferation, invasion, angiogenesis, and survival, greatly potentiating TNF-α-mediated cell death in HeLa and HepG2 cancer cells. The gene discussed is TNF; the disease is cancer.